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 Remote ischaemic conditioning is a powerful and highly reproducible cytoprotective 
intervention demonstrable in a wide range of animal models1. To an extent, remote 
ischaemic conditioning – the phenomena whereby transient, non-lethal ischaemia of 
a distal tissue bed triggers visceral pro-survival adaption against a lethal ischaemic 
insult – has also been demonstrable in man, although the necessary landmark clinical 
outcome study has yet to yield the results necessary for adoption into routine clinical 
practice. 
Remote ischaemic conditioning (RIC) is such a remarkably simple intervention with 
such a low intrinsic cost in its most simplistic application (manual inflation/deflation 
of a sphygmomanometer cuff) that it is very attractive to study RIC’s efficacy to 
mitigate ischaemia-related injury in a wide range of pathologies and organ systems. 
This approach appears to be entirely appropriate: in a variety of experimental settings, 
remote ischaemic conditioning has proven to be remarkably adept in attenuating 
ischaemia/reperfusion injury in a variety of organ systems2, including heart3, kidney4, 
liver5 and brain6.  
In the Safety and Efficacy of Remote Ischemic conditioning in patients with Severe 
carotid Artery Stenosis Prior to Carotid Artery Stenting study, Ji et al. present an 
intriguing proof-of-concept trial of RIC to ameliorate the complications of distal 
thrombo-embolization associated with elective carotid artery stenting (CAS) for 
severe carotid stenosis. Elective procedures are the ideal setting for ischaemic pre-
conditioning (where the conditioning stimulus is applied prior to the anticipated 
ischaemic insult), and this is the first time remote ischaemic preconditioning has been 
applied to protect the brain against an embolic complication arising from an elective 
vascular intervention. 
CAS is preferred over carotid endarterectomy (CEA) in patients with high surgical risk, 
and recent trial data suggest equipoise between the two techniques in intermediate 
risk patient cohorts and for those selected patients with asymptomatic disease. Thus, 
in international guidelines7, CAS has an increasing role in the management of carotid 
artery stenosis, but one of the problems associated with the procedure is the risk of 
thromboembolism and subsequent ischaemic cerebral injury8. If a neuroprotective 
intervention could be brought to bear to mitigate the potential risk, the current 
equipoise may be tipped in favour of the minimally invasive CAS procedure. 
Therefore, it is both welcome and encouraging that Ji et al. report that their remote 
ischemic conditioning protocol was highly effective in reducing cerebral infarct size 
following CAS for both severe asymptomatic and symptomatic carotid stenosis. 
As a proof-of-concept, the result is exciting, but should of course be taken with some 
caution: as with our own and others’ experience in the context of RIC in cardiac 
surgery, positive proof-of-concept clinical trials do not inevitably lead to positive 
clinical outcome studies, as exemplified by the ERICCA9 and RIPHeart10. 
In this study, looking at the safety and efficacy of RIC in CAS, it is inevitable that the 
hard clinical outcomes – TIA and stroke – were not significantly different between 
groups (although the number of events in the RIC group was numerically lower); the 
trial, by design, was not powered to detect such a difference. Surrogate endpoint 
analysis, however, revealed a significant benefit in the reduction of DWI lesion volume 
(0.03ml as compared to sham or control, 0.07 and 0.08ml respectively, p<0.001), 
despite the number of new lesions detected by DWI not being different between 
groups. This observation would support the anti-ischaemic hypothesis of ischaemic 
conditioning; the anti-inflammatory hypothesis seemingly not detectable in the 
measurement of the biomarkers used in the study (hsCRP), nor, oddly, was a 
detectable change in NSE and S100-b, markers of neurological injury.  
Of course, although the results of this study are encouraging, before ischaemic 
conditioning can be adopted for clinical use, the benefits of the intervention need to 
be realised in an appropriately powered outcome study.  In the case of CAS, one would 
wish to see that the reduction of DWI volume with RIC be translated into a real-world 
benefit in terms of stroke, TIA or cognitive preservation and improvement in measures 
of quality of life.  
A commendable feature of this study was the inclusion of a realistic sham control 
group, where the two upper arm blood pressure cuffs were inflated to 60mmHg. This 
inflation pressure has the advantage that the patient will be aware of the cuff gaining 
pressure on the arm, giving the impression of a genuine therapy administration. This 
is more likely to lead to more effective patient blinding as the patient is much less 
likely to recognise the sham procedure as such. Importantly, the 60mmHg will not 
impede arterial flow in the upper limb to trigger tissue ischaemia, although venous 
flow will be impeded. To counter against the potential for venous stagnation 
contributing to a RIC-like effect, a second control group was included, where no cuff 
was applied. Interestingly, there was no observable difference between the sham and 
the no-intervention control groups. This approach to sham-controlled RIC study 
design could pave the way for a similar approach to be applied in future sham-control 
studies: the prior norm for sham interventions has been for lower cuff inflation 
pressures, typically below the venous occlusion pressure, may be less effective at 
patient blinding. 
This study however raises an important question that all researchers in the field of RIC 
investigations will be aware. Ji et al. have used a very robust ischaemic conditioning 
protocol of twice daily, two-arm, five cycle (five minute ischaemia/five minute 
reperfusion) performed over a period of two weeks prior to surgery. In the majority 
of prior clinical studies in different clinical settings, the implementation of RIC as 
preconditioning has been three to four cycles of five minute ischaemia/ five minute 
reperfusion typically applied to one (very rarely to two) limbs just the once within 40-
60 minutes of the index ischaemic event. The RIC protocol in this trial is quite unusual 
(even compared to the their own post-stroke study, where RIC was applied as 
conditioning stimulus once daily to two arms over a period of 300 days to prevent 
recurrent stroke11) and one wonders whether this is, in fact, the optimum conditioning 
protocol to elicit the observed outcome. The problem is that in man, as in animals, 
there is a remarkable scarcity of data to support any one particular remote ischaemic 
conditioning protocol over another. In the literature, there has been a creeping 
increase in the number of cycles of conditioning: a remote ischaemic conditioning 
“arms” race, with no discernible end in sight. An increased conditioning stimulus may 
in part be justified, as research has revealed that cardiovascular morbidities (such as 
age, hypertension, diabetes12) make it harder to trigger cardioprotective-signalling 
cascades, with comorbidities apparently increasing the threshold of cycles required to 
trigger protection. Thus, rightly or wrongly, to enable the wide applicability of 
conditioning, more robust conditioning regimes have been employed to yield a better 
theoretical outcome. But does more always lead to more? In direct ischaemic 
conditioning of the organ to be subjected to lethal ischaemia/reperfusion injury, the 
answer is certainly not: the dose-response curve is “U”-shaped, with greater number 
of ischaemic cycles and duration leading to a plateau of effectiveness, or even 
increased injury13. Moreover, daily conditioning regimes (for example with 
pharmacological agonists) don’t always lead to optimum protection and perhaps best 
served by an alternate-day regime14. Thus, there is currently no clear, optimal 
conditioning regimen. To adequately address this problem is clearly a challenge, 
perhaps one borne out of a lack of a clear biomarker for protection other than the 
attenuation of ischaemic injury (infarct size) that is typically the primary endpoint of 
the interventional study. Be it a challenge or not, it is nonetheless incumbent upon 
researchers to work out the most efficacious conditioning strategy that results in the 
least discomfiture to the patients that we seek to help. 
Positive outcome studies are the key to unlocking the clinical potential of this cheap 
and easily-applied protective RIC strategy, but the demonstration of a neuroprotective 
effect of RIC should provide encouragement for further research in this important area 
of cardiovascular medicine and represents the necessary foundations for future larger 
outcome-based studies to further optimise patient outcomes in those presenting with 
severe carotid stenosis. 
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